| Application no. and date | 17724760.8 (espacenet) (Federated) (European Patent Register), 20170426 | | Patent/reg. no. and date | DK/EP 3458085, 20221207 | | Publication date | 20190327 | | Priority no. and date | EP 16170690, 20160520 | | EP pub. no. and date |
EP 3458085 20190327 | | Effective date | | | Applicant/owner | Octapharma AG, Seidenstrasse 2
8853 Lachen, CH | | Applicant ref. no. | PV1942DKEP | | Inventor | KANNICHT, Christoph, Dieffenbachstrasse 33
10967 Berlin, DE,
SCHWIENTEK, Tilo, Kuhweg 13
41468 Neuss, DE,
SOLECKA-WITULSKA, Barbara, Beymestrasse 13
12167 Berlin, DE,
WINGE, Stefan, Långhalsvågen 17, 2tr
1250 Årsta, SE | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 38/36 (2006.01) | | Title | GLYKOSYLERET VWF-FUSIONSPROTEINER MED FORBEDRET FARMAKOKINETIK | | Int. application no. | EP2017059976 | | Int. publication no. | WO2017198435 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
